- Home
- PPBT vs VEEE Comparison
PPBT vs VEEE Comparison
Compare PPBT & VEEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- VEEE
- Stock Information
- Founded
- PPBT 2010
- VEEE 1994
- Country
- PPBT Israel
- VEEE United States
- Employees
- PPBT N/A
- VEEE N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- VEEE Marine Transportation
- Sector
- PPBT Health Care
- VEEE Industrials
- Exchange
- PPBT Nasdaq
- VEEE Nasdaq
- Market Cap
- PPBT 6.2M
- VEEE 5.1M
- IPO Year
- PPBT N/A
- VEEE 2021
- Fundamental
- Price
- PPBT $2.08
- VEEE $2.19
- Analyst Decision
- PPBT Strong Buy
- VEEE
- Analyst Count
- PPBT 1
- VEEE 0
- Target Price
- PPBT $33.00
- VEEE N/A
- AVG Volume (30 Days)
- PPBT 258.8K
- VEEE 35.3K
- Earning Date
- PPBT 08-15-2025
- VEEE 08-13-2025
- Dividend Yield
- PPBT N/A
- VEEE N/A
- EPS Growth
- PPBT N/A
- VEEE N/A
- EPS
- PPBT N/A
- VEEE N/A
- Revenue
- PPBT N/A
- VEEE $12,724,465.00
- Revenue This Year
- PPBT N/A
- VEEE N/A
- Revenue Next Year
- PPBT N/A
- VEEE N/A
- P/E Ratio
- PPBT N/A
- VEEE N/A
- Revenue Growth
- PPBT N/A
- VEEE N/A
- 52 Week Low
- PPBT $2.00
- VEEE $2.05
- 52 Week High
- PPBT $13.95
- VEEE $9.30
- Technical
- Relative Strength Index (RSI)
- PPBT 32.49
- VEEE 41.91
- Support Level
- PPBT $2.35
- VEEE $2.20
- Resistance Level
- PPBT $2.90
- VEEE $2.43
- Average True Range (ATR)
- PPBT 0.17
- VEEE 0.12
- MACD
- PPBT -0.06
- VEEE -0.00
- Stochastic Oscillator
- PPBT 1.20
- VEEE 39.25
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power boats to use for fishing, diving and water skiing, and commercial activities including transportation, eco-tours, fishing, and diving expeditions. The company offers various boat models, including Twin Vee 400 GFX2 CC, Twin Vee 280 GFX2 CC, and Twin Vee 260 Center Console STX, among others. Its products are marketed under two brands, Twin Vee for its catamarans, or dual-hull vessels, and Aquasport for its V-hull boats. The company sells its boats through a network of independent boat dealers across North America, the Caribbean, and Central America who resell the boats to the end user, Twin Vee customers.